Kyntra Bio Inc Net Income per Employee (KYNB), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kyntra Bio Inc   (NASDAQ: KYNB)
 

Kyntra Bio Inc Net Income per Employee

KYNB's Quarterly Results, Trends, Rankings, Statistics
Kyntra Bio Inc 's Income per employee fell in the first quarter 2026 on a trailing twelve month basis to $ 4,812,206, but the productivity of Kyntra Bio Inc 's 34 employees remained above the company average.
The Healthcare sector has seen employees of 7 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 41, from total ranking in previous quarter at 65.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KYNB Net Income per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 4,812,206 5,395,647 6,342,765 -60,765 -294,324
KYNB's Total Ranking # 41 # 65 # 33 # 3026 # 3546
Seq. Net Income Change - - - - -74.2 %

KYNB Company Profile >> Back to KYNB Efficiency Comparisons >> Compare KYNB Net Income per Employee to its Competitors

KYNB Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 8
Overall Market # 41

Net Income per Employee Statistics
High Average Low
$ 6,342,765 $ -3,995,090 $ -10,634,029
(Sep 30 2025)   (Sep 30 2022)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Oncotelic Therapeutics Inc   6,503,944.82 $ 247.150  Million 38 
Ligand Pharmaceuticals Incorporated  3,267,212.77 $ 153.559  Million 47 
Innoviva Inc   3,171,974.84 $ 504.344  Million 159 


Date modified: 2026-08-29T17:23:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.